Suscripción a Biblioteca: Guest
Critical Reviews™ in Oncogenesis

Publicado 4 números por año

ISSN Imprimir: 0893-9675

ISSN En Línea: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

HIV-1 Vaccine Candidate Evaluation in Non-Human Primates

Volumen 8, Edición 2-3, 1997, pp. 273-291
DOI: 10.1615/CritRevOncog.v8.i2-3.50
Get accessGet access

SINOPSIS

The development of an HIV-1 vaccine in the last 13 years from an industrial point of view has focused on evaluating potential vaccine candidates in non-human primates. This review discusses the HJV-1 vaccine candidates that have been tested in chimpanzees or monkeys and includes those based on recombinant gpl20, recombinant gpl60, different viral and bacterial vectors expressing gpl20. gpl60, or only V3 peptide, naked DNA vaccines, and whole inactivated viruses. To help understand the result of efficacy studies in chimpanzees and monkeys, information regarding the challenge viruses used in these studies is also included. The review does not discuss the testing of SIV-related vaccines or the testing of HIV-1 vaccine candidates in other animal species other than non-human primates.

CITADO POR
  1. MATHIESON BONNIE J., HIV VACCINES: MILESTONES AND NEW INSIGHTS, in Sexually Transmitted Diseases, 2000. Crossref

  2. Ely John J., Dye Brent, Frels William I., Fritz Jo, Gagneux Pascal, Khun Henry H., Switzer William M., Lee D. Rick, Subspecies composition and founder contribution of the captive U.S. chimpanzee (Pan troglodytes) population, American Journal of Primatology, 67, 2, 2005. Crossref

  3. Hirsch Vanessa M., Lifson Jeffrey D., Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and Prevention, in HIV-1: Molecular Biology and Pathogenesis, 49, 2000. Crossref

  4. Falk Lydia A., Goldenthal Karen L., Esparza Jose, Aguado M. Teresa, Osmanov Saladin, Ballou W. Ripley, Recombinant Bacillus Calmette-Guerin as a Potential Vector for Preventive HIV Type 1 Vaccines, AIDS Research and Human Retroviruses, 16, 2, 2000. Crossref

  5. Ahmed Raija K.S., Biberfeld Gunnel, Thorstensson Rigmor, Innate immunity in experimental SIV infection and vaccination, Molecular Immunology, 42, 2, 2005. Crossref

  6. Schmaljohn Connie, Custer David, VanderZanden Lorna, Spik Kristin, Rossi Cynthia, Bray Mike, Evaluation of Tick-Borne Encephalitis DNA Vaccines in Monkeys, Virology, 263, 1, 1999. Crossref

  7. Forns Xavier, Payette Paul J., Ma Xiaoying, Satterfield William, Eder Gerald, Mushahwar Isa K., Govindarajan Sugantha, Davis Heather L., Emerson Suzanne U., Purcell Robert H., Bukh Jens, Vaccination of Chimpanzees With Plasmid DNA Encoding the Hepatitis C Virus(HCV) Envelope E2 Protein Modified the Infection After Challenge With Homologous Monoclonal HCV, Hepatology, 32, 3, 2000. Crossref

  8. Lu Yichen, Pauza C. David, Lu Xusheng, Montefiori David C., Miller Christopher J., Rhesus Macaques That Become Systemically Infected With Pathogenic SHIV 89.6-PD After Intravenous, Rectal, or Vaginal Inoculation and Fail to Make an Antiviral Antibody Response Rapidly Develop AIDS, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 19, 1, 1998. Crossref

  9. Lu Yichen, Essex Max, Lentivirus‡, in The Springer Index of Viruses, 2011. Crossref

  10. Roberts Bryan, Lu Yichen, Infectious Diseases in Asia, in AIDS in Asia, 2004. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain